Apnimed CFO holds options for 333,580 shares

Apnimed, Inc. (APMD) reported the initial beneficial ownership of its Chief Financial Officer, Michael B. Kelly, on a Form 3.

Rhea-AI Filing Summary

Apnimed, Inc. (APMD) reported the initial beneficial ownership of its Chief Financial Officer, Michael B. Kelly, on a Form 3. Kelly holds a stock option to purchase 333,580 shares of Class A Common Stock at an exercise price of $8.15 per share, expiring on June 23, 2036, held directly.

According to the vesting terms, 25% of the option shares vest and become exercisable after twelve months of continuous service following June 22, 2026, and the remaining shares vest in substantially equal monthly installments over the subsequent 36 months, subject to his continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kelly Michael B

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy) F1	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 333,580 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Key Figures

Underlying shares: 333,580 shares Exercise price: $8.15 per share Option expiration date: June 23, 2036 +2 more

5 metrics

Underlying shares 333,580 shares Underlying Class A Common Stock for CFO stock option holding

Exercise price $8.15 per share Exercise price of Stock Option (Right to Buy) held directly

Option expiration date June 23, 2036 Expiration date of CFO’s stock option position

Initial vesting portion 25% Portion of option shares that vest after 12 months from June 22, 2026

Subsequent vesting period 36 months Remaining shares vest monthly over 36 months after the initial 12-month period

Key Terms

Stock Option (Right to Buy), Class A Common Stock, continuous service, vest and become exercisable

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Class A Common Stock financial

"underlying_security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

continuous service financial

"when the Reporting Person completes twelve months of continuous service after June 22, 2026"

vest and become exercisable financial

"25% of the shares subject to such option vest and become exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider holdings did Apnimed (APMD) disclose for CFO Michael B. Kelly on this Form 3?

The filing shows Michael B. Kelly holds a stock option for 333,580 shares of Apnimed Class A Common Stock, with an exercise price of $8.15 per share and an expiration date of June 23, 2036, held directly.

What is the exercise price of Michael B. Kelly’s stock option reported by Apnimed (APMD)?

The stock option reported for Michael B. Kelly has an exercise price of $8.15 per share. It covers 333,580 underlying shares of Class A Common Stock and expires on June 23, 2036, subject to the specified vesting schedule and continued service.

How many shares underlie the stock option held by Apnimed (APMD)’s CFO?

The stock option held by Apnimed’s CFO, Michael B. Kelly, covers 333,580 underlying shares of Class A Common Stock. These shares are subject to vesting, with a 25% cliff after twelve months from June 22, 2026, then monthly vesting over 36 months.

When do Michael B. Kelly’s Apnimed (APMD) stock options start vesting and on what schedule?

The option begins vesting after twelve months of continuous service following June 22, 2026. At that point, 25% of the shares vest, with the remaining shares vesting in substantially equal monthly installments over the next 36 months, contingent on continued service.

What is the expiration date of the Apnimed (APMD) stock option reported for the CFO?

The stock option reported for Apnimed’s CFO expires on June 23, 2036. It grants the right to buy 333,580 shares of Class A Common Stock at $8.15 per share, subject to the outlined vesting conditions and his ongoing service with the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 07:35 PM Accepted by SEC EDGAR 07/30/2026 - 04:29 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kelly Michael B

(Last) (First) (Middle)

APNIMED, INC.

39 JOHN F. KENNEDY STREET, 4TH FLOOR.

(Street)

CAMBRIDGE MASSACHUSETTS 02138

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/30/2026

3. Issuer Name and Ticker or Trading Symbol
Apnimed, Inc. [ APMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	06/23/2036	Class A Common Stock	333,580	$8.15	D

Explanation of Responses:

1. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/Kevin R. Lind, Attorney-in-Fact	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)